Immunome Inc. SEC filings IMNM
Immunome Inc. has 460 filings in SEC EDGAR's recent list, going back to Sep 14, 2009. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 5, 2026 (material agreement, unregistered share sale). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Nov 27, 2023 | — |
| CORRESP | Letter to the SEC | Nov 22, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 20, 2023 | — |
| 425 | Filing | Sep 21, 2023 | — |
| EFFECT | Filing | Aug 28, 2023 | — |
| CORRESP | Letter to the SEC | Aug 25, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 11, 2023 | — |
| 425 | Filing | Jul 5, 2023 | — |
| 425 | Filing | Jun 29, 2023 | — |
| 425 | Filing | Jun 29, 2023 | — |
| EFFECT | Filing | Oct 14, 2021 | — |
| CORRESP | Letter to the SEC | Oct 12, 2021 | — |
| UPLOAD | Letter from the SEC | Oct 8, 2021 | — |
| EFFECT | Filing | Jun 1, 2021 | — |
| CORRESP | Letter to the SEC | May 28, 2021 | — |
| CORRESP | Letter to the SEC | May 21, 2021 | — |
| UPLOAD | Letter from the SEC | May 17, 2021 | — |
| D | Filing | May 11, 2021 | — |
| EFFECT | Filing | Oct 1, 2020 | — |
| CERT | Filing | Oct 1, 2020 | — |
| SEC STAFF LETTER | Filing | Sep 30, 2020 | — |
| 8-A12B | Filing | Sep 30, 2020 | — |
| CORRESP | Letter to the SEC | Sep 29, 2020 | — |
| CORRESP | Letter to the SEC | Sep 29, 2020 | — |
| SEC STAFF LETTER | Filing | Sep 21, 2020 | — |
| CORRESP | Letter to the SEC | Sep 9, 2020 | — |
| UPLOAD | Letter from the SEC | Sep 1, 2020 | — |
| DRS | Filing | Aug 12, 2020 | — |
| D/A | Filing | Jun 16, 2020 | — |
| D | Filing | Jun 1, 2020 | — |
| D | Filing | Nov 19, 2019 | — |
| D/A | Filing | May 29, 2019 | — |
| D | Filing | Feb 1, 2019 | — |
| D | Filing | May 30, 2017 | — |
| D | Filing | Jul 14, 2016 | — |
| D | Filing | Dec 2, 2015 | — |
| D/A | Filing | Apr 13, 2015 | — |
| D | Filing | Oct 14, 2014 | — |
| D/A | Filing | Mar 19, 2014 | — |
| D | Filing | Mar 3, 2014 | — |
| D | Filing | Feb 20, 2013 | — |
| D | Filing | Jan 27, 2012 | — |
| D/A | Filing | Jun 8, 2011 | — |
| D/A | Filing | Oct 5, 2010 | — |
| D/A | Filing | Oct 4, 2010 | — |
| D | Filing | May 3, 2010 | — |
| D | Filing | Sep 14, 2009 | — |
Showing 47 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- IMNM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Bothell, WA
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1472012
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.